Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Min‐Ying Su
Choline as a Biomarker for Cell Proliferation: Do the Results From Proton MR Spectroscopy Show Difference Between HER2/neu Positive and Negative Breast Cancers?
International Journal of Cancer
Cancer Research
Oncology
Related publications
Do Multifocal or Multicentric pT1a Node-Negative HER2+ Breast Cancers Get Benefit From Systemic Treatment?
Breast Cancer Research and Treatment
Cancer Research
Oncology
A Phenotypic and Mechanistic Perspective on Heterogeneity of HER2-positive Breast Cancers
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Positive Response to Neoadjuvant Cyclophosphamide and Doxorubicin in Topoisomerase II Nonamplified/Her2/Neu Negative/Polysomy 17 Absent Breast Cancer Patients
Cancer Management and Research
Oncology
Functional Implications of Structural Predictions for Alternative Splice Proteins Expressed in Her2/Neu–Induced Breast Cancers
Journal of Proteome Research
Biochemistry
Chemistry
miR-17 as a Diagnostic Biomarker Regulates Cell Proliferation in Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
MiR-190b, the Highest Up-Regulated miRNA in ERα-positive Compared to ERα-negative Breast Tumors, a New Biomarker in Breast Cancers?
BMC Cancer
Cancer Research
Oncology
Genetics
Identification of New miRNA Biomarkers Associated With HER2-positive Breast Cancers
Oncoscience
Cancer Research
Oncology
ZW25 Active in HER2-positive Cancers
Cancer Discovery
Oncology
Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer
Journal of Molecular Biomarkers & Diagnosis
